Menu Search
Equities

Raia Drogasil S/A

RADL3:SAO

Raia Drogasil S/A

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (BRL)25.49
  • Today's Change0.12 / 0.47%
  • Shares traded498.20k
  • 1 Year change-10.25%
  • Beta0.6122
Data delayed at least 15 minutes, as of Nov 22 2024 15:10 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
  • 21-Nov-24
Select bar for recommendation details.
Recommendations21-Nov-24
Buy2
Outperform6
Hold4
Sell0
Strong Sell1

Share price forecast in BRL

The 12 analysts offering 12 month price targets for Raia Drogasil S/A have a median target of 30.50, with a high estimate of 35.00 and a low estimate of 23.00. The median estimate represents a 20.22% increase from the last price of 25.37.
High38.0%35.00
Med20.2%30.50
Low-9.3%23.00

Dividends in BRL

In 2023, Raia Drogasil S/A reported a dividend of 0.30 BRL, which represents a 24.43% increase over last year. The 11 analysts covering the company expect dividends of 0.27 BRL for the upcoming fiscal year, a decrease of 11.03%.
Div growth (TTM)24.43%
More ▼

Earnings history & estimates in BRL

On Nov 05, 2024, Raia Drogasil S/A reported 3rd quarter 2024 earnings of 0.201 per share. This result exceeded the 0.17 consensus of the 4 analysts covering the company and exceeded last year's 3rd quarter results by 25.63%.
The next earnings announcement is expected on Mar 03, 2025.
Average growth rate+12.73%
Raia Drogasil S/A reported annual 2023 earnings of 0.67 per share on Mar 05, 2024.
Average growth rate+16.66%
More ▼

Revenue history & estimates in BRL

Raia Drogasil S.A. had 3rd quarter 2024 revenues of 9.99bn. This missed the 10.29bn consensus estimate of the 6 analysts following the company. This was 25.94% above the prior year's 3rd quarter results.
Average growth rate+3.60%
Raia Drogasil S.A. had revenues for the full year 2023 of 33.97bn. This was 16.88% above the prior year's results.
Average growth rate+18.06%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.